ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,690, issued on June 10, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.).

"Compounds for the reducing lipotoxic damage" was invented by Vijay P. Singh (Scottsdale, Ariz.), Sampath-Kumar Anandan (Fremont, Calif.), Kevin Greenman (Sunnyvale, Calif.) and Zeeshan Kamal (Milpitas, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are novel lipase inhibitors and methods for using the same to treat inflammation, multisystem organ failure, necrotic pancreatic acinar cell death, acute pancreatitis, sepsis (e.g., culture negative sepsis), burns, and acne. For example, provided herein are two novel lipas...